FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...